Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 23Unknown 13Recruiting 13Terminated 4Not yet recruiting 3Active not recruiting 2Withdrawn 1

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gynecologic 2Gastrointestinal 1

Conditions

Breast Neoplasms 630Prostatic Neoplasms 372Neoplasms 305Carcinoma, Non-Small-Cell Lung 215Lung Neoplasms 204Colorectal Neoplasms 176Multiple Myeloma 143Pancreatic Neoplasms 136Leukemia, Myeloid, Acute 128Neoplasm Metastasis 124Brain Neoplasms 117Melanoma 116Ovarian Neoplasms 101Carcinoma, Hepatocellular 101Precursor Cell Lymphoblastic Leukemia-Lymphoma 100Glioblastoma 99Uterine Cervical Neoplasms 97Head and Neck Neoplasms 94Squamous Cell Carcinoma of Head and Neck 93Colonic Neoplasms 82Stomach Neoplasms 80Recurrence 80Rectal Neoplasms 80Urinary Bladder Neoplasms 77Sarcoma 77Carcinoma, Renal Cell 76Triple Negative Breast Neoplasms 75Lymphoma 71Lymphoma, Non-Hodgkin 67Leukemia, Lymphocytic, Chronic, B-Cell 66

Interventions

Surveys and Questionnaires 1Re-Irradiation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × OTHER × Pelvic Neoplasms × Clear all
NCT04713618 2026-05-07

GEORGIA

Ohio State University Comprehensive Cancer Center

Active not recruiting
72 enrolled
GastrointestinalGynecologic

Anus Neoplasms, Uterine Cervical Neoplasms, Pelvic Neoplasms, Rectal Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

NCT06397573 2026-02-17

Ablative Stereotactic MR-Guided Adaptive Reirradiation

Baptist Health South Florida

Phase NA Active not recruiting
10 enrolled
Gynecologic

Pelvic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡